From sample treatment to biomarker discovery: A tutorial for untargeted metabolomics based on GC-(EI)-Q-MS

Analytica Chimica Acta

Volumn 900, Issue , 2015, Pages 21-35

  Mastrangelo, Annalaura ^a   Ferrarini, Alessia ^a   Rey Stolle, Fernanda ^a   García, Antonia ^a   Barbas, Coral ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Database; Fingerprinting; GC MS; Global profiling; Metabolomics; Methodology

Indexed keywords

DATABASE SYSTEMS; DIGITAL STORAGE;

FINGERPRINTING; GC-MS; GLOBAL PROFILING; METABOLOMICS; METHODOLOGY;

DATA HANDLING;

3 HYDROXYBUTYRIC ACID; BIOLOGICAL MARKER;

ANALYTIC METHOD; BIOCHEMISTRY; BLOOD ANALYSIS; CALIBRATION; CASE STUDY; DERIVATIZATION; ETHICS; EXPERIMENTAL DESIGN; INFORMATION PROCESSING; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL VALIDATION; UNIVARIATE ANALYSIS; VALIDATION PROCESS; METABOLISM; PROCEDURES;

BIOMARKERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS;

EID: 84960445225     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.10.001     Document Type: Review

References (86)

1. Lei Z., Huhman D.V., Sumner L.W. Mass spectrometry strategies in metabolomics. J. Biol. Chem. 2011, 286(29):25435-25442.
2. Koek M.M., Jellema R.H., van der Greef J., Tas A.C., Hankemeier T. Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics 2011, 7(3):307-328.
3. Halket J.M., Waterman D., Przyborowska A.M., Patel R.K., Fraser P.D., Bramley P.M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J. Exp. Bot. 2005, 56(410):219-243.
4. Godzien J., Ciborowski M., Angulo S., Barbas C. From numbers to a biological sense: How the strategy chosen for metabolomics data treatment may affect final results. A practical example based on urine fingerprints obtained by LC-MS. Electrophoresis 2013, 34(19):2812-2826.
5. Leon Z., Garcia-Canaveras J.C., Donato M.T., Lahoz A. Mammalian cell metabolomics: experimental design and sample preparation. Electrophoresis 2013, 34(19):2762-2775.
6. Kamlage B., Maldonado S.G., Bethan B., Peter E., Schmitz O., Liebenberg V., Schatz P. Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin. Chem. 2014, 60(2):399-412.
7. Tuck M.K., Chan D.W., Chia D., Godwin A.K., Grizzle W.E., Krueger K.E., Rom W., Sanda M., Sorbara L. Stass S and others. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J. Proteome Res. 2009, 8(1):113-117.
8. Dunn W.B., Wilson I.D., Nicholls A.W., Broadhurst D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 2012, 4(18):2249-2264.
9. Naz S., Moreira Dos Santos D.C., Garcia A., Barbas C. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues. Bioanalysis 2014, 6(12):1657-1677.
10. Jiye A., Trygg J., Gullberg J., Johansson A.I., Jonsson P., Antti H., Marklund S.L., Moritz T. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal. Chem. 2005, 77(24):8086-8094.
11. Little J.L. Artifacts in trimethylsilyl derivatization reactions and ways to avoid them. J. Chromatogr. A 1999, 844(1-2):1-22.
12. Dunn W.B., Broadhurst D., Ellis D.I., Brown M., Halsall A., O'Hagan S., Spasic I., Tseng A., Kell D.B. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int. J. Epidemiol. 2008, 37(Suppl 1):i23-30. England.
13. Begley P., Francis-McIntyre S., Dunn W.B., Broadhurst D.I., Halsall A., Tseng A., Knowles J., Goodacre R., Kell D.B. Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. Anal. Chem. 2009, 81(16):7038-7046.
14. Kind T., Tolstikov V., Fiehn O., Weiss R.H. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal. Biochem. 2007, 363:185-195. United States.
15. Koek M.M., Muilwijk B., van der Werf M.J., Hankemeier T. Microbial metabolomics with gas chromatography/mass spectrometry. Anal. Chem. 2006, 78(4):1272-1281.
16. Weimer B., Slupsky C.M. Metabolomics in Food and Nutrition 2013, Woodhead Publishing.
17. Zaikin V., Halket J.M. A Handbook of Derivatives for Mass Spectrometry 2009, IM Publications.
18. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., Brown M., Knowles J.D., Halsall A., Haselden J.N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 2011, 6(7):1060-1083.
19. Chen M., Rao R.S., Zhang Y., Zhong C.X., Thelen J.J. A modified data normalization method for GC-MS-based metabolomics to minimize batch variation. Springerplus 2014, 3:439.
20. Nezami Ranjbar M.R., Luo Y., Di Poto C., Varghese R.S., Ferrarini A., Zhang C., Sarhan N.I., Soliman H., Tadesse M.G. Ziada DH and others. GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort. PLoS One 2015, 10(6):e0127299.
21. Horwitz W. The variability of AOAC methods of analysis as used in analytical pharmaceutical chemistry. J. Assoc. Off. Anal. Chem. 1977, 60(6):1355-1363.
22. Nielsen J., Jewett M.C. Metabolomics. A Powerful Tool in Systems Biology 2007, Springer.
23. Gika H.G., Macpherson E., Theodoridis G.A., Wilson I.D. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J. Chromatogr. B 2008, 871(2):299-305.
24. Sangster T., Major H., Plumb R., Wilson A.J., Wilson I.D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 2006, 131(10):1075-1078.
25. Godzien J., Alonso-Herranz V., Barbas C., Armitage E. Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample. Metabolomics 2014, 1-11.
26. Smart K.F., Aggio R.B., Van Houtte J.R., Villas-Boas S.G. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography-mass spectrometry. Nat. Protoc. 2010, 5(10):1709-1729.
27. Hiller K., Hangebrauk J., Jager C., Spura J., Schreiber K., Schomburg D. MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal. Chem. 2009, 81(9):3429-3439.
28. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78(3):779-787.
29. Gowda H., Ivanisevic J., Johnson C.H., Kurczy M.E., Benton H.P., Rinehart D., Nguyen T., Ray J., Kuehl J. Arevalo B and others. Interactive XCMS Online: simplifying advanced metabolomic data processing and subsequent statistical analyses. Anal. Chem. 2014, 86(14):6931-6939.
30. Weckwerth W., Morgenthal K. Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today 2005, 10(22):1551-1558.
31. Du X., Zeisel S.H. Spectral Deconvolution for Gas Chromatography Mass Spectrometry-Based Metabolomics: Current Status and Future Perspectives. Comput. Struct. Biotechnol. J. 2013, 4(5). 10.5936/csbj.201301013.
32. Halket J.M., Przyborowska A., Stein S.E., Mallard W.G., Down S., Chalmers R.A. Deconvolution gas chromatography/mass spectrometry of urinary organic acids-potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun. Mass Sp. 1999, 13(4):279-284.
33. Aggio R., Villas-Boas S.G., Ruggiero K. Metab: an R package for high-throughput analysis of metabolomics data generated by GC-MS. Bioinformatics 2011, 27(16):2316-2318.
34. Behrends V., Tredwell G.D., Bundy J.G. A software complement to AMDIS for processing GC-MS metabolomic data. Anal. Biochem. 2011, 415(2):206-208.
35. Stein S.E. An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J. Am. Soc. Mass Spectr. 1999, 10(8):770-781.
36. Axelson D.E. Data Preprocessing for Chemometric and Metabonomic Analysis 2012, CreateSpace Independent Publishing Platform.
37. Gromski P.S., Xu Y., Kotze H.L., Correa E., Ellis D.I., Armitage E.G., Turner M.L., Goodacre R. Influence of missing values substitutes on multivariate analysis of metabolomics data. Metabolites 2014, 4:433-452. Switzerland.
38. Bijlsma S., Bobeldijk I., Verheij E.R., Ramaker R., Kochhar S., Macdonald I.A., van Ommen B., Smilde A.K. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 2006, 78(2):567-574.
39. Katajamaa M., Oresic M. Processing methods for differential analysis of LC/MS profile data. BMC Bioinforma. 2005, 6(179). 10.1186/1471-2105-6-179.
40. Sysi-Aho M., Katajamaa M., Yetukuri L., Oresic M. Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinforma. 2007, 8(93). 10.1186/1471-2105-8-93.
41. Kultima K., Nilsson A., Scholz B., Rossbach U.L., Falth M., Andren P.E. Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides. Mol. Cell Proteomics 2009, 8(10):2285-2295.
42. Warrack B.M., Hnatyshyn S., Ott K.H., Reily M.D., Sanders M., Zhang H., Drexler D.M. Normalization strategies for metabonomic analysis of urine samples. J. Chromatogr. B 2009, 877(5-6):547-552.
43. Veselkov K.A., Vingara L.K., Masson P., Robinette S.L., Want E., Li J.V., Barton R.H., Boursier-Neyret C., Walther B., Ebbels T.M., et al. Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem. 2011, 83(15):5864-5872.
44. van den Berg R.A., Hoefsloot H.C., Westerhuis J.A., Smilde A.K., van der Werf M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7(142). 10.1186/1471-2164-7-142.
45. Steuer R., Morgenthal K., Weckwerth W., Selbig J. A gentle guide to the analysis of metabolomic data. Methods in Molecular Biology 2007, vol. 358:105-126. Humana Press. W. Weckwerth (Ed.).
46. Weckwerth W. Integration of metabolomics and proteomics in molecular plant physiology-coping with the complexity by data-dimensionality reduction. Physiol. Plant. 2008, 132(2):176-189.
47. Altaf-Ul-Amin M., Afendi F.M., Kiboi S.K., Kanaya S. Systems biology in the context of big data and networks. Biomed. Res. Int. 2014, 2014:428570.
48. Okada T., Afendi F.M., Altaf-Ul-Amin M., Takahashi H., Nakamura K., Kanaya S. Metabolomics of medicinal plants: the importance of multivariate analysis of analytical chemistry data. Curr. Comput-Aid Drug 2010, 6(3):179-196.
49. Ghosh S., Matsuoka Y., Asai Y., Hsin K.Y., Kitano H. Software for systems biology: from tools to integrated platforms. Nat. Rev. Genet. 2011, 12(12):821-832.
50. Waterman D.S., Bonner F.W., Lindon J.C. Spectroscopic and statistical methods in metabonomics. Bioanalysis 2009, 1(9):1559-1578.
51. Madsen R., Lundstedt T., Trygg J. Chemometrics in metabolomics-A review in human disease diagnosis. Anal. Chim. Acta 2010, 659(1-2):23-33.
52. Gromski P.S., Muhamadali H., Ellis D.I., Xu Y., Correa E., Turner M.L., Goodacre R. A tutorial review: Metabolomics and partial least squares-discriminant analysis-a marriage of convenience or a shotgun wedding. Anal. Chim. Acta 2015, 879:10-23.
53. Shapiro S.S., Wilk M.B. An Analysis of Variance Test for Normality (Complete Samples). Biometrika 1965, 52(3-4):591-611.
54. Srivastava M.S., Hui T.K. On assessing multivariate normality based on shapiro-wilk W statistic. Stat. Probabil Lett. 1987, 5(1):15-18.
55. Henderson A.R. Testing experimental data for univariate normality. Clin. Chim. Acta 2006, 366(1-2):112-129.
56. Lilliefors H.W. On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown. J. Am. Stat. Assoc. 1967, 62(318):399-402.
57. Sawilowsky S.S. Fermat, Schubert, Einstein, and Behrens-Fisher: The Probable Difference Between Two Means When σ12≠ σ22. J. Mod. Appl. Stat. Methods 2002, 1(2):461-472.
58. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6(2):469-479.
59. Taylor J., King R.D., Altmann T., Fiehn O. Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformatics 2002, 18(2):241-248.
60. Mahadevan S., Shah S.L., Marrie T.J., Slupsky C.M. Analysis of metabolomic data using support vector machines. Anal. Chem. 2008, 80(19):7562-7570.
61. Xia J., Wishart D.S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 2011, 6(6):743-760.
62. Conneely K.N., Boehnke M. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am. J. Hum. Genet. 2007, 81(6):1158-1168.
63. Broadhurst D., Kell D. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006, 2(4):171-196.
64. Holm S.A. Simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6(2):65-70.
65. Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J. Roy. Stat. Soc. B Met. 1995, 57(1):289-300.
66. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing. Ann. Stat. 2001, 29(4):919-1188.
67. Storey J.D. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann. Stat. 2003, 31(6):1695-2095.
68. Xie G., Chen T., Qiu Y., Shi P., Zheng X., Su M., Zhao A., Zhou Z., Jia W. Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics 2012, 8(2):220-231.
69. Denery J.R., Nunes A.A., Hixon M.S., Dickerson T.J., Janda K.D. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl. Trop. D. 2010, 4(10):e834.
70. Matsuda F., Shinbo Y., Oikawa A., Hirai M.Y., Fiehn O., Kanaya S., Saito K. Assessment of metabolome annotation quality: a method for evaluating the false discovery rate of elemental composition searches. PLoS One 2009, 4(10):e7490.
71. Kos G., Lohninger H., Krska R. Validation of chemometric models for the determination of deoxynivalenol on maize by mid-infrared spectroscopy. Mycotoxin Res. 2003, 19(2):149-153.
72. Ciborowski M., Lipska A., Godzien J., Ferrarini A., Korsak J., Radziwon P., Tomasiak M., Barbas C. Combination of LC-MS- and GC-MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood. J. Proteome Res. 2012, 11(12):6231-6241.
73. Ferrarini A., Ruperez F.J., Erazo M., Martinez M.P., Villar-Alvarez F., Peces-Barba G., Gonzalez-Mangado N., Troncoso M.F., Ruiz-Cabello J., Barbas C. Fingerprinting based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: a pilot study. Electrophoresis 2013, 34(19):2873-2881.
74. Ciborowski M., Teul J., Martin-Ventura J.L., Egido J., Barbas C. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint. PLoS One 2012, 7(2):e31982.
75. Rubingh C.M., Bijlsma S., Derks E.P., Bobeldijk I., Verheij E.R., Kochhar S., Smilde A.K. Assessing the performance of statistical validation tools for megavariate metabolomics data. Metabolomics 2006, 2:53-61.
76. Wiklund S. Multivariate data analysis for omics. Umetrics 2008, 37-43. http://metabolomics.se/Courses/MVA/MVA%20in%20Omics_Handouts_Exercises_Solutions_Thu-Fri.pdf.
77. Jansen J.J., Szymanska E., Hoefsloot H.C., Jacobs D.M., Strassburg K., Smilde A.K. Between Metabolite Relationships: an essential aspect of metabolic change. Metabolomics 2012, 8(3):422-432.
78. Zhang S., Nagana Gowda G.A., Asiago V., Shanaiah N., Barbas C., Raftery D. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal. Biochem. 2008, 383(1):76-84.
79. Bujak R., Garcia-Alvarez A., Ruperez F.J., Nuno-Ayala M., Garcia A., Ruiz-Cabello J., Fuster V., Ibanez B., Barbas C. Metabolomics reveals metabolite changes in acute pulmonary embolism. J. Proteome Res. 2014, 13(2):805-816.
80. Dudzik D., Zorawski M., Skotnicki M., Zarzycki W., Kozlowska G., Bibik-Malinowska K., Vallejo M., Garcia A., Barbas C., Ramos M.P. Metabolic fingerprint of Gestational Diabetes Mellitus. J. Proteomics 2014, 103:57-71.
81. Canuto G.A., Castilho-Martins E.A., Tavares M.F., Rivas L., Barbas C., Lopez-Gonzalvez A. Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania. Anal. Bioanal. Chem. 2014, 406(14):3459-3476.
82. Naz S., Garcia A., Barbas C. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue. Anal. Chem. 2013, 85(22):10941-10948.
83. Navarrete A., Armitage E.G., Musteanu M., Garcia A., Mastrangelo A., Bujak R., Lopez-Casas P.P., Hidalgo M., Barbas C. Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer. Pharmacol. Res. Perspect. 2014, 2(6):e00067.
84. Villasenor A., Garcia-Perez I., Garcia A., Posma J.M., Fernandez-Lopez M., Nicholas A.J., Modi N., Holmes E., Barbas C. Breast milk metabolome characterization in a single-phase extraction, multiplatform analytical approach. Anal. Chem. 2014, 86(16):8245-8252.
85. Pan J.W., Rothman T.L., Behar K.L., Stein D.T., Hetherington H.P. Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J. Cerebr Blood F. Met. 2000, 20(10):1502-1507.
86. Kind T., Wohlgemuth G., Lee D.Y., Lu Y., Palazoglu M., Shahbaz S., Fiehn O. FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry. Anal. Chem. 2009, 81(24):10038-10048.